2-Methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 97%, 250mg

N,N'-Diphenyl-N,N'-di(p-tolyl)benzidine>98.0%(GC)200mg

(4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97%, 250mg

2,2'-Dihydroxy-1H,1'H-[2,2'-biindene]-1,1',3,3'(2H,2'H)-tetraone dihydrate, 97%, 100g

3-(Methylthio)-6,7-dihydrobenzo[c]thiophen-4(5H)-one, 97%, 100mg

(Difluoromethyl)benzene, 97.0%, 10g

Morpholine-4-sulfonyl chloride, 98.00%, 10g

6-Heptynoic acid, 95.0%, 10g

4-(Dimethylamino)-3-methylbenzaldehyde, 97.0%, 5g

1-(3-Hydroxyphenyl)-piperazine, 98.0%, 25g

1-Propylpiperidin-4-amine dihydrochloride, 95.0%, 1g

Tetracloroetileno, mínimo 99,5 %, para síntesis, 2,5 L, envase de vidrio

2-azaspiro[4.4]nonan-3-one, 95.0%, 5g